{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:39:35Z","timestamp":1759991975259},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1994,6,1]],"date-time":"1994-06-01T00:00:00Z","timestamp":770428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1994,6]]},"DOI":"10.1007\/bf01974636","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T19:23:33Z","timestamp":1123010613000},"page":"468-474","source":"Crossref","is-referenced-by-count":6,"title":["Beta-lactam resistance amongEscherichia coli andKlebsiella species blood culture isolates in Finnish hospitals"],"prefix":"10.1007","volume":"13","author":[{"given":"T.","family":"Arstila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Huovinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Finnish Study Group for Antimicrobial Resistance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01974636_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JCM.20.1.65-69.1984","volume":"20","author":"P Huovinen","year":"1984","unstructured":"Huovinen P, Gr\u00f6nroos P, Herva E, Katila M-L, Klossner M-L, Renkonen O-V, Toivanen P: Aminoglycoside resistance among blood culture isolates. Journal of Clinical Microbiology 1984, 20: 65\u201369.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01974636_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/24.suppl_B.1","volume":"24","author":"B Wiedemann","year":"1989","unstructured":"Wiedemann B, Kliebe C, Kresken M: The epidemiology of \u03b2-lactamases. Journal of Antimicrobial Chemotherapy 1989, 24: 1\u201322.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01974636_CR3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/BF01984932","volume":"10","author":"T Arstila","year":"1991","unstructured":"Arstila T, Huovinen S, Huovinen P: Analysis of beta-lactamase production in ampicillin-resistantEscherichia coli isolated from blood cultures 1983\u20131989. European Journal of Clinical Microbiology and Infectious Diseases 1991, 10: 1068\u20131070.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"BF01974636_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF01964244","volume":"10","author":"S Huovinen","year":"1988","unstructured":"Huovinen S, Huovinen P, Torniainen K, Jacob GA: Evaluation of plasmid-encoded beta-lactamase resistance inEscherichia coli blood culture isolates. European Journal of Clinical Microbiology and Infectious Diseases 1988, 10: 651\u2013655.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"BF01974636_CR5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","volume":"34","author":"LB Rice","year":"1990","unstructured":"Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC, Jacoby GA: Outbreak of ceftazidime resistance caused by extended-spectrum \u03b2-lactamases at a Massachusetts chronic-care facility. Antimicrobial Agents and Chemotherapy 1990, 34: 2193\u20132199.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0278-2316(92)90043-D","volume":"11","author":"JP Quinn","year":"1992","unstructured":"Quinn JP: Novel plasmid-mediated extended spectrum beta-lactamases. Infectious Diseases Newsletter 1992, 11: 33\u201340.","journal-title":"Infectious Diseases Newsletter"},{"key":"BF01974636_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AAC.33.6.951","volume":"33","author":"L Gutmann","year":"1989","unstructured":"Gutmann L, Ferre B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E: SHV-5, a novel SHV-type \u03b2-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy 1989, 33: 951\u2013956.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR8","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","volume":"35","author":"GA Jacoby","year":"1991","unstructured":"Jacoby GA, Medeiros AA: More extended-spectrum \u03b2-lactamases. Antimicrobial Agents and Chemotherapy 1991, 35: 1697\u20131704.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR9","series-title":"Approved standard","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"1990","unstructured":"National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2, NCCLS, Villanova, PA, 1990."},{"key":"BF01974636_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/AAC.32.2.175","volume":"32","author":"S Huovinen","year":"1988","unstructured":"Huovinen S, Huovinen P, Jacoby GA: Detection of plasmid-mediated \u03b2-lactamases with DNA probes. Antimicrobial Agents and Chemotherapy 1988, 32: 175\u2013179.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0003-2697(83)90418-9","volume":"132","author":"AP Feinberg","year":"1983","unstructured":"Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 1983, 132: 6\u201313.","journal-title":"Analytical Biochemistry"},{"key":"BF01974636_CR12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1128\/AAC.36.9.1877","volume":"36","author":"KS Thompson","year":"1992","unstructured":"Thompson KS, Sanders CC: Detection of extended-spectrum \u03b2-lactamases in members of the familyEnterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrobial Agents and Chemotherapy 1992, 36: 1877\u20131882.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(87)90891-9","volume":"ii","author":"C Brun-Buisson","year":"1987","unstructured":"Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J: Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistantKlebsiella pneumoniae. Lancet 1987, ii: 302\u2013306.","journal-title":"Lancet"},{"key":"BF01974636_CR14","volume-title":"Anatomical therapuetic chemical classification index including defined daily doses for plain substances","author":"WHO Collaboration Centre for Drug Statistics Methology","year":"1992","unstructured":"WHO Collaboration Centre for Drug Statistics Methology: Anatomical therapuetic chemical classification index including defined daily doses for plain substances. WHO, Oslo, Norway, 1992."},{"key":"BF01974636_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/31.1.29","volume":"31","author":"R Reig","year":"1993","unstructured":"Reig R, Roy C, Hermida M, Teruel D, Coira A: A survey of \u03b2-lactamases from 618 isolated ofKlebsiella spp. Journal of Antimicrobial Chemotherapy 1993, 31: 29\u201335.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01974636_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/29.3.345","volume":"29","author":"G Katsanis","year":"1992","unstructured":"Katsanis G, Jacoby G: The frequency of extended-spectrum \u03b2-lactamases in isolates ofKlebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 1992, 29: 345\u2013353.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01974636_CR17","volume-title":"Nordic statistics on medicines 1987\u20131989. NNC Publciation 30","author":"Noridc Council on Medicines","year":"1990","unstructured":"Noridc Council on Medicines: Nordic statistics on medicines 1987\u20131989. NNC Publciation 30. Nordiska L\u00e4kemedelsn\u00e4mnden, Uppsala, Sweden, 1990."},{"key":"BF01974636_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/27.3.255","volume":"27","author":"DJ Payne","year":"1991","unstructured":"Payne DJ, Amyes SGB: Transferable resistance to extended-spectrum \u03b2-lactams: a major threat or a minor inconvenience? Journal of Antimicrobial Chemotherapy 1991, 27: 255\u2013261.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01974636_CR19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/clind\/15.5.824","volume":"15","author":"CC Sanders","year":"1992","unstructured":"Sanders CC, Sanders WE: \u03b2-lactam resistance in gramnegative bacteria: global trends and clinical impact. Clinical Infectious Diseases 1992, 15: 824\u2013839.","journal-title":"Clinical Infectious Diseases"},{"key":"BF01974636_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0140-6736(90)91784-8","volume":"336","author":"N Woodford","year":"1990","unstructured":"Woodford N, Payne DJ, Johnson AP, Weinbren MJ, Perinpanayagam RM, George RC, Cookson BD, Amyes SGB: Transferable cephalosporin resistance not inhibited by clavulanate inEscherichia coli. Lancet 1990, 336: 253.","journal-title":"Lancet"},{"key":"BF01974636_CR21","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.34.11.2200","volume":"34","author":"GA Papanicolaou","year":"1990","unstructured":"Papanicolaou GA, Medeiros AA, Jacoby GA: Novel plasmid-mediated \u03b2-lactamase (MIR-1) conferring resistance to oxyimino- and \u03b1-methoxy-\u03b2-lactams in clinical isolates ofKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1990, 34: 2200\u20132209.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01974636_CR22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.37.10.2059","volume":"37","author":"J Blazquez","year":"1993","unstructured":"Blazquez J, Baquero M-R, Canton R, Alos I Baquero F: Characterization of the new TEM-type \u03b2-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate ofEscherichia coli. Antimicrobial Agents and Chemotherapy 1993, 37: 2059\u20132063.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01974636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01974636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01974636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:37:35Z","timestamp":1586345855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01974636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1994,6]]}},"alternative-id":["BF01974636"],"URL":"https:\/\/doi.org\/10.1007\/bf01974636","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[1994,6]]}}}